RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
88 hedge funds and large institutions have $655M invested in Revance Therapeutics, Inc. in 2015 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 37 increasing their positions, 16 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
26% more funds holding
Funds holding: 70 → 88 (+18)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
88
Holding in Top 10
2
Calls
$2.17M
Puts
$269K
Top Buyers
| 1 | +$21.6M | |
| 2 | +$7.76M | |
| 3 | +$6.44M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.73M |
| 5 |
JPMorgan Chase & Co
New York
|
+$5.5M |
Top Sellers
| 1 | -$23.1M | |
| 2 | -$10.6M | |
| 3 | -$8.98M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$4.15M |
| 5 |
Goldman Sachs
New York
|
-$3.39M |